Flea, Tick And Heartworm Products Market To Reach $10.90 Billion By 2030

Flea, Tick And Heartworm Products Market Growth & Trends

The global flea, tick and heartworm products market size is expected to reach USD 10.90 billion by 2030, registering a CAGR of 7.4% from 2024 to 2030, according to a new report by Grand View Research, Inc. The market is experiencing an upsurge in developing and launching innovative products. These products can effectively manage parasitic complications in cats & dogs and prove to be a useful parallel option for treatment for pet owners and veterinarians. One such prominent example is flea & tick control collars. These products are just like normal pet collars but contain a specific drug capable of repelling the infestation of fleas, ticks and mosquitoes for some time.

 Apart from Seresto by Elanco, other emerging and established players are actively investing in the development of similar collars but utilize novel approaches to enhance infestation control. These launches can also be considered attempts by other companies to capture the market amidst the lawsuit against Seresto Collar. For example, in January 2024, Neogen Corporation launched a collar named Provecta. This collar uses a combination of drugs called deltamethrin and methoprene to inhibit flea and tick growth in dogs and cats. This collar claims to provide six months of protection from fleas, ticks, and mosquitoes.

Furthermore, approvals for injectable products capable of providing long-term animal protection are further intensifying the competitive rivalry. For example, in May 2023, Merck Animal Health received approval for the Bravecto Quantum sale in Australia. This injectable parasiticide can provide over one year of protection against fleas & ticks. Such instances act as catalysts in driving the market by promoting innovative product development that can effectively address the gaps in the prevention & treatment of FTH complications in animals.

Another crucial driver of the demand for these flea, tick and heartworm products is the rising cases of flea and tick infestation in animals worldwide. For example, according to a May 2024 study published in the Veterinary Medicine & Science Journal, the prevalence of fleas and ticks in dogs from the African country of Ethiopia was estimated to be 69.7% and 36.7%, respectively.

Moreover, across the world, in India, the infestation rate of ticks was estimated to be 57.1% in dogs, according to the January 2024 study published in the Acarological Studies Journal. Furthermore, a March 2023 study published in Psyche Journal of Entomology estimated that the prevalence of fleas and ticks in cats from Iran was around 89% and 63%, respectively. This high infestation rate of parasites like fleas and ticks points towards the growing need for effective products to bring this infestation under control, hence boosting market growth.

 Request a free sample copy or view report summary: Flea, Tick And Heartworm Products Market Report

Flea, Tick And Heartworm Products Market Report Highlights

• Based on product, the treatment products segment accounted for the largest revenue share of 76.00% in 2023. This segment is further divided into products like spot-on, oral pills/chewables, sprays, liquid solutions, shampoos, etc. This spot-on product took the highest share owing to its ease of access, greater absorption, and effective treatment.

• Based on type, the prescription segment dominated the with a market share of over 60.00% in 2023. Most flea and tick medications doctors prescribe are taken orally, typically as a tasty, chewable tablet or applied topically for ectoparasites like fleas & ticks.

• Based on animal, the canine segment dominated with a share of over 48.00% in 2023 because dogs are the primary species affected by FTH complications, and there are several flea, tick, and heartworm preventative and treatment options available for dogs. The market has grown due to an increasing prevalence of parasite infection in the canine population.

• Based on mode of delivery, the topical segment dominated the market in 2023 due to its advantages over oral flea, tick, and heartworm medications. One of the primary advantages of topical flea treatments is that many are not systemically absorbed, which means they do not penetrate the skin barrier or enter a pet's bloodstream. This may be advantageous for animals with a history of adverse drug reactions or who have not previously responded well to oral flea treatments.

• Based on parasite, the external parasite segment dominated the market in 2023. This is attributable to the high prevalence of external parasites like fleas and ticks among dogs and cats.

• Based on care, the preventive care segment held the dominant revenue share in 2023 and is expected to witness the fastest CAGR over the forecast period. This can be attributed to the fact that veterinarians, as well as animal welfare organizations throughout the world, focus on taking preventive measures for flea, tick and heartworm complications.

• Based on distribution channel, the online segment is estimated to grow the most over the forecast period. This growth is driven by factors such as increasing penetration of online pharmacies in under-developed and developing economies, increasing variety of OTC products, and, most importantly, the convenience of procuring flea, tick and heartworm products.

• In 2023, North America accounted for the largest market share of 39.71%. The number of Americans who own pets is increasing, which is driving up demand for flea, tick and heartworm products. The region's need for FTH products is also anticipated to grow as the incidence of illnesses caused by fleas, ticks, and heartworms in pets rises.

• The Asia Pacific (APAC) market is anticipated to grow at a CAGR of over 8.9% over the forecast period owing to this high transmission rate of vector-borne infections in dogs & cats in the region, and the need for appropriate veterinary medications.

Flea, Tick And Heartworm Products Market Segmentation

Grand View Research has segmented the global flea, tick and heartworm products market based on product, type, animal, mode of delivery, parasite, care, distribution channel, and region:

Flea, Tick And Heartworm Product Outlook (Revenue, USD Million, 2018 - 2030)

• Diagnostic Products

  • Test Kits

  • Consumables

• Treatment Products

  • Spot on

  • Oral pills/Chewable

  • Spray

  • Liquid Solution

  • Shampoo

  • Others

Flea, Tick And Heartworm Products Type Outlook (Revenue, USD Million, 2018 - 2030)

• Prescription

• OTC

Flea, Tick And Heartworm Products Animal Outlook (Revenue, USD Million, 2018 - 2030)

• Canine

• Feline

• Others

Flea, Tick And Heartworm Products Mode of Delivery Outlook (Revenue, USD Million, 2018 - 2030)

• Topical

• Oral

• Injectable

Flea, Tick And Heartworm Products Parasite Outlook (Revenue, USD Million, 2018 - 2030)

• External Parasite

• Internal Parasite

Flea, Tick And Heartworm Products Care Outlook (Revenue, USD Million, 2018 - 2030)

• Preventive Care

• Therapeutic Care

Flea, Tick And Heartworm Products Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)

• Hospital/Clinic Pharmacy

• Retail Pharmacy

• Online Pharmacy

Flea, Tick And Heartworm Product Regional Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • India

  • China

  • South Korea

  • Australia

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East and Africa (MEA)

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the Flea, Tick And Heartworm Products Market

• Zoetis

• Boehringer Ingelheim

• Merck & Co. Inc

• Virbac

• Elanco

• Ceva

• Promika, LLC

• Sergeant's Pet Care Products, Inc.

• Adams

• BioNote Inc.

• Secure Diagnostics Ltd.

• iNtRON Biotechnology

• Biopanda Reagents Ltd.